{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:51:03Z","timestamp":1794037863442,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although diabetes mellitus is an established risk factor for acute myocardial infarction (AMI), epidemiological studies showed wide variations in the incidence of AMI in people with diabetes and inconsistent time trends. The objectives of the present systematic review were as follows: (i) to analyze the age\u2013sex-adjusted incidence of both non-fatal and fatal AMI in people with diabetes compared to those without diabetes, (ii) to investigate corresponding time trends, and (iii) to identify sex differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search was performed in the literature databases MEDLINE, Embase, and LILACS until July 19, 2023, to identify population-based studies reporting the incidence of AMI in people with diabetes compared to those without diabetes according to our predefined inclusion criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 28 population-based cohort studies were included in this review. In women with diabetes, the incidence of AMI ranged from 102 to 690 per 100,000 person-years, and in men with diabetes from 206 to 1630. Estimates comparing people with and without diabetes ranged from 1.55 (95% CI 1.44\u20131.67) to 14.37 (8.43\u201324.47) in women and from 1.33 (1.18\u20131.51) to 4.17 (2.72\u20136.37) in men. Over the past four decades, the incidence of AMI declined in almost all studies in people without diabetes, but only in half of the studies in people with diabetes. There was considerable heterogeneity with regard to the definition of AMI, the population with diabetes, and geographic differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Incidence of AMI in people with diabetes remained significantly higher than in those without diabetes. A reduction in the incidence of AMI over time was observed in some, but not all reviewed studies in people with diabetes. There was no discernible trend of estimates comparing people with and without diabetes. These findings underscore the necessity for additional initiatives to prevent coronary heart disease in people with diabetes. The observed discrepancy in study results is presumably attributable to variations in the population and regional contexts, as well as to disparate methodological approaches. More standardized studies employing comparable methodologies are therefore required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42 02014 5562<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-026-03089-x","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T04:20:15Z","timestamp":1770610815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of acute myocardial infarction in people with diabetes compared to those without diabetes: a systematic review"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0527-3142","authenticated-orcid":false,"given":"Maria","family":"Narres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Kvitkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Ubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Inti","family":"Metzendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Icks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"3089_CR1","unstructured":"IDF Diabetes Atlas 11th edition. https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/."},{"key":"3089_CR2","unstructured":"World Health Organization, World Heart Federation. Global atlas on cardiovascular disease prevention and control 2011. https:\/\/apps.who.int\/iris\/handle\/10665\/44701."},{"key":"3089_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11886-019-1107-y","volume":"21","author":"D Glovaci","year":"2019","unstructured":"Glovaci D, Fan W, Wong ND. Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Curr Cardiol Rep. 2019;21:21.","journal-title":"Curr Cardiol Rep"},{"key":"3089_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00125-018-4796-7","volume":"62","author":"SH Read","year":"2019","unstructured":"Read SH, Fischbacher CM, Colhoun HM, Gasevic D, Kerssens JJ, McAllister DA, et al. Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015. Diabetologia. 2019;62:418\u201325.","journal-title":"Diabetologia"},{"key":"3089_CR5","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.2337\/dc19-2363","volume":"43","author":"M de Jong","year":"2020","unstructured":"de Jong M, Woodward M, Peters SAE. Diabetes, glycated hemoglobin, and the risk of myocardial infarction in women and men: a prospective cohort study of the UK Biobank. Diabetes Care. 2020;43:2050\u20139.","journal-title":"Diabetes Care"},{"key":"3089_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/dom.12827","volume":"19","author":"NN Gholap","year":"2017","unstructured":"Gholap NN, Achana FA, Davies MJ, Ray KK, Gray L, Khunti K. Long-term mortality after acute myocardial infarction among individuals with and without diabetes: a systematic review and meta-analysis of studies in the post-reperfusion era. Diabetes Obes Metab. 2017;19:364\u201374.","journal-title":"Diabetes Obes Metab"},{"key":"3089_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijcard.2016.04.182","volume":"217","author":"C Bauters","year":"2016","unstructured":"Bauters C, Lemesle G, de Groote P, Lamblin N. A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction. Int J Cardiol. 2016;217:109\u201321.","journal-title":"Int J Cardiol"},{"key":"3089_CR8","unstructured":"International Diabetes Federation. IFD Diabetes and Cardiovascular Disease. Report 2022. https:\/\/idf.org\/our-activities\/care-prevention\/cardiovascular-disease\/cvd-report.html?sub-content-tab-nav."},{"key":"3089_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1464-5491.1990.tb01405.x","volume":"7","author":"The Saint Vincent","year":"1990","unstructured":"The Saint Vincent. Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med. 1990;7:360.","journal-title":"Diabet Med"},{"key":"3089_CR10","doi-asserted-by":"crossref","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW: Global trends in diabetes complications: a review of current evidence. Diabetologia. 2018.","DOI":"10.1007\/s00125-018-4711-2"},{"key":"3089_CR11","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.2019.3471","volume":"321","author":"EW Gregg","year":"2019","unstructured":"Gregg EW, Hora I, Benoit SR. Resurgence in diabetes-related complications. JAMA. 2019;321:1867\u20138.","journal-title":"JAMA"},{"key":"3089_CR12","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/eurheartj\/ehn250","volume":"29","author":"NC Barengo","year":"2008","unstructured":"Barengo NC, Katoh S, Moltchanov V, Tajima N, Tuomilehto J. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J. 2008;29:1889\u201395.","journal-title":"Eur Heart J"},{"key":"3089_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.annepidem.2014.05.007","volume":"24","author":"AP Carson","year":"2014","unstructured":"Carson AP, Tanner RM, Yun H, Glasser SP, Woolley JM, Thacker EL, et al. Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes. Ann Epidemiol. 2014;24:581\u20137.","journal-title":"Ann Epidemiol"},{"key":"3089_CR14","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990\u20132010. N Engl J Med. 2014;370:1514\u201323.","journal-title":"N Engl J Med"},{"key":"3089_CR15","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s00125-009-1434-4","volume":"52","author":"A Icks","year":"2009","unstructured":"Icks A, Dickhaus T, Hormann A, Heier M, Giani G, Kuch B, et al. Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: monitoring trends and determinants on cardiovascular diseases (MONICA)\/cooperative health research in the region of Augsburg (KORA) registry. Diabetologia. 2009;52:1836\u201341.","journal-title":"Diabetologia"},{"key":"3089_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-017-0580-0","volume":"16","author":"AA Laverty","year":"2017","unstructured":"Laverty AA, Bottle A, Kim SH, Visani B, Majeed A, Millett C, et al. Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004\u20132014. Cardiovasc Diabetol. 2017;16:100.","journal-title":"Cardiovasc Diabetol"},{"key":"3089_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-015-0607-7","volume":"17","author":"MO Gore","year":"2015","unstructured":"Gore MO, McGuire DK, Lingvay I, Rosenstock J. Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges. Curr Cardiol Rep. 2015;17:607.","journal-title":"Curr Cardiol Rep"},{"key":"3089_CR18","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","volume":"57","author":"SA Peters","year":"2014","unstructured":"Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57:1542\u201351.","journal-title":"Diabetologia"},{"key":"3089_CR19","doi-asserted-by":"publisher","first-page":"R245","DOI":"10.1530\/EJE-14-0401","volume":"171","author":"P Anagnostis","year":"2014","unstructured":"Anagnostis P, Majeed A, Johnston DG, Godsland IF. Cardiovascular risk in women with type 2 diabetes mellitus and prediabetes: is it indeed higher than men? Eur J Endocrinol. 2014;171:R245-255.","journal-title":"Eur J Endocrinol"},{"key":"3089_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2337\/diacare.26.2.360","volume":"26","author":"M Woodward","year":"2003","unstructured":"Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003;26:360\u20136.","journal-title":"Diabetes Care"},{"key":"3089_CR21","first-page":"1099","volume":"28","author":"VP Miranda","year":"2009","unstructured":"Miranda VP, Rodrigues MJ, Gon\u00e7alves FR, Nunes JP. Effects of hypoglycemic agents on mortality and major cardiovascular outcomes in patients with type 2 diabetes mellitus: a narrative review [88]. Rev Port Cardiol. 2009;28:1099\u2013119.","journal-title":"Rev Port Cardiol"},{"key":"3089_CR22","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215\u201322.","journal-title":"Lancet"},{"key":"3089_CR23","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"3089_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89.","journal-title":"Syst Rev"},{"key":"3089_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-022-01962-z","volume":"11","author":"M Narres","year":"2022","unstructured":"Narres M, Kvitkina T, Claessen H, Ubach E, Wolff G, Metzendorf MI, et al. Incidence of myocardial infarction in people with diabetes compared to those without diabetes: a systematic review protocol. Syst Rev. 2022;11:89.","journal-title":"Syst Rev"},{"key":"3089_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-2","volume":"5","author":"P Royle","year":"2005","unstructured":"Royle P, Bain L, Waugh N. Systematic reviews of epidemiology in diabetes: finding the evidence. BMC Med Res Methodol. 2005;5:2.","journal-title":"BMC Med Res Methodol"},{"key":"3089_CR27","first-page":"6039356","volume":"2017","author":"P Ballotari","year":"2017","unstructured":"Ballotari P, Venturelli F, Greci M, Giorgi Rossi P, Manicardi V. Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy. Int J Endocrinol Print. 2017;2017:6039356.","journal-title":"Int J Endocrinol Print"},{"key":"3089_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14806","volume":"39","author":"E Dybjer","year":"2022","unstructured":"Dybjer E, Dahl Aslan AK, Engstr\u00f6m G, Nilsson ED, N\u00e4gga K, Nilsson PM, et al. Type 1 diabetes, cognitive ability and incidence of cardiovascular disease and death over 60 years of follow-up time in men. Diabet Med. 2022;39:e14806.","journal-title":"Diabet Med"},{"key":"3089_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2337\/diacare.20.6.935","volume":"20","author":"AR Folsom","year":"1997","unstructured":"Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1997;20:935\u201342.","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"3089_CR30","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/diab.45.3.S14","volume":"45","author":"M Fujishima","year":"1996","unstructured":"Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama study. Diabetes. 1996;45(Suppl 3):S14-16.","journal-title":"Diabetes"},{"key":"3089_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-8-17","volume":"8","author":"M Hyv\u00e4rinen","year":"2009","unstructured":"Hyv\u00e4rinen M, Tuomilehto J, Laatikainen T, S\u00f6derberg S, Eliasson M, Nilsson P, et al. The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender. Cardiovasc Diabetol. 2009;8:17.","journal-title":"Cardiovasc Diabetol"},{"key":"3089_CR32","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.2337\/diacare.27.12.2898","volume":"27","author":"A Juutilainen","year":"2004","unstructured":"Juutilainen A, Kortelainen S, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27:2898\u2013904.","journal-title":"Diabetes Care"},{"key":"3089_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1753-0407.12380","volume":"9","author":"F Liu","year":"2017","unstructured":"Liu F, Yang X, Li J, Cao J, Chen J, Li Y, et al. Association of fasting glucose levels with incident atherosclerotic cardiovascular disease: An 8-year follow-up study in a Chinese population. J Diabetes. 2017;9:14\u201323.","journal-title":"J Diabetes"},{"key":"3089_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2796.1997.tb00006.x","volume":"241","author":"V Lundberg","year":"1997","unstructured":"Lundberg V, Stegmayr B, Asplund K, Eliasson M, Huhtasaari F. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Intern Med. 1997;241:485\u201392.","journal-title":"J Intern Med"},{"key":"3089_CR35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1136\/heartjnl-2016-311050","volume":"103","author":"V Matuleviciene-An\u00e4ngen","year":"2017","unstructured":"Matuleviciene-An\u00e4ngen V, Rosengren A, Svensson AM, Pivodic A, Gudbj\u00f6rnsdottir S, Wedel H, et al. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes. Heart. 2017;103:1687\u201395.","journal-title":"Heart"},{"key":"3089_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4247","volume":"363","author":"ERC Millett","year":"2018","unstructured":"Millett ERC, Peters SAE, Woodward M. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ. 2018;363:k4247.","journal-title":"BMJ"},{"key":"3089_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00125-014-3388-4","volume":"58","author":"B Moe","year":"2015","unstructured":"Moe B, Augestad LB, Flanders WD, Dalen H, Nilsen TI. The adverse association of diabetes with risk of first acute myocardial infarction is modified by physical activity and body mass index: prospective data from the HUNT study, Norway. Diabetologia. 2015;58:59\u201366.","journal-title":"Diabetologia"},{"key":"3089_CR38","first-page":"453","volume":"27","author":"A O\u011fuz","year":"2023","unstructured":"O\u011fuz A, K\u0131l\u0131\u00e7kap M, Gule\u00e7 S, Altunta\u015f Y, Kar\u015f\u0131da\u011f K, Temizhan A, et al. Risk factors, use of preventive drugs, and cardiovascular events in diabetes mellitus: the PURE T\u00fcrkiye cohort. Anatol J Cardiol. 2023;27:453\u201361.","journal-title":"Anatol J Cardiol"},{"key":"3089_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2796.2005.01552.x","volume":"258","author":"A Rautio","year":"2005","unstructured":"Rautio A, Lundberg V, Messner T, Nasic S, Stegmayr B, Eliasson M. Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989\u20132000. J Intern Med. 2005;258:369\u201377.","journal-title":"J Intern Med"},{"key":"3089_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2011.01.021","volume":"216","author":"I Saito","year":"2011","unstructured":"Saito I, Kokubo Y, Yamagishi K, Iso H, Inoue M, Tsugane S. Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) study. Atherosclerosis. 2011;216:187\u201391.","journal-title":"Atherosclerosis"},{"key":"3089_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000967","volume":"6","author":"M Tancredi","year":"2019","unstructured":"Tancredi M, Rosengren A, Svensson AM, Pivodic A, Gudbjornsdottir S, Wedel H, et al. Glycaemic control and excess risk of major coronary events in patients with type 2 diabetes: a population-based study. Open Heart. 2019;6:e000967.","journal-title":"Open Heart"},{"key":"3089_CR42","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jdiacomp.2013.12.004","volume":"28","author":"VG Vimalananda","year":"2014","unstructured":"Vimalananda VG, Biggs ML, Rosenzweig JL, Carnethon MR, Meigs JB, Thacker EL, et al. The influence of sex on cardiovascular outcomes associated with diabetes among older black and white adults. J Diabetes Complications. 2014;28:316\u201322.","journal-title":"J Diabetes Complications"},{"key":"3089_CR43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1001\/archinternmed.2011.2","volume":"171","author":"SG Wannamethee","year":"2011","unstructured":"Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011;171:404\u201310.","journal-title":"Arch Intern Med"},{"key":"3089_CR44","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1161\/CIRCULATIONAHA.118.039100","volume":"139","author":"AK Wright","year":"2019","unstructured":"Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus: a population-based cohort study assessing sex disparities. Circulation. 2019;139:2742\u201353.","journal-title":"Circulation"},{"key":"3089_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229\u201334.","journal-title":"N Engl J Med"},{"key":"3089_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108126","volume":"36","author":"CH N\u00f8rgaard","year":"2022","unstructured":"N\u00f8rgaard CH, Starkopf L, Gerds TA, Malmborg M, Bonde AN, Zareini B, et al. Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease. J Diabetes Complications. 2022;36:108126.","journal-title":"J Diabetes Complications"},{"key":"3089_CR47","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/bmj.299.6708.1127","volume":"299","author":"A Rosengren","year":"1989","unstructured":"Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ. 1989;299:1127\u201331.","journal-title":"BMJ"},{"key":"3089_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12933-022-01498-5","volume":"21","author":"M Saeed","year":"2022","unstructured":"Saeed M, Stene LC, Ariansen I, Tell GS, Tapia G, Joner G, et al. Nine-fold higher risk of acute myocardial infarction in subjects with type 1 diabetes compared to controls in Norway 1973\u20132017. Cardiovasc Diabetol. 2022;21:59.","journal-title":"Cardiovasc Diabetol"},{"key":"3089_CR49","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","volume":"117","author":"TK Schramm","year":"2008","unstructured":"Schramm TK, Gislason GH, K\u00f8ber L, Rasmussen S, Rasmussen JN, Abildstr\u00f8m SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117:1945\u201354.","journal-title":"Circulation"},{"key":"3089_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30435","volume":"4","author":"HI Hyacinth","year":"2021","unstructured":"Hyacinth HI, Franceschini N, Seals SR, Irvin MR, Chaudhary N, Naik RP, et al. Association of sickle cell trait with incidence of coronary heart disease among African American individuals. JAMA Netw Open. 2021;4:e2030435.","journal-title":"JAMA Netw Open"},{"key":"3089_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.18865\/ed.32.3.193","volume":"32","author":"CSG Murray","year":"2022","unstructured":"Murray CSG, Zamora C, Shitole SG, Christa P, Lee UJ, Bortnick AE, et al. Race-ethnic differences of ST-elevation myocardial infarction: findings from a New York health system registry. Ethn Dis. 2022;32:193\u2013202.","journal-title":"Ethn Dis"},{"key":"3089_CR52","unstructured":"Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Geneva: World Health Organization. Copyright \u00a9 World Health Organization 1999."},{"key":"3089_CR53","unstructured":"Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: WHO Guidelines Approved by the Guidelines Review Committee. Abbreviated Report of a WHO Consultation. Geneva: World Health Organization. Copyright \u00a9 World Health Organization 2011."},{"key":"3089_CR54","doi-asserted-by":"crossref","unstructured":"The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41:105\u2013114.","DOI":"10.1016\/0895-4356(88)90084-4"},{"key":"3089_CR55","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","volume":"36","author":"JS Alpert","year":"2000","unstructured":"Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined\u2013a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"3089_CR56","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618\u201351.","journal-title":"Circulation"},{"key":"3089_CR57","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551\u201367.","journal-title":"Eur Heart J"},{"key":"3089_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2021.101226","volume":"47","author":"D Angoulvant","year":"2021","unstructured":"Angoulvant D, Ducluzeau PH, Renoult-Pierre P, Fauchier G, Herbert J, Semaan C, et al. Impact of gender on relative rates of cardiovascular events in patients with diabetes. Diabetes Metab. 2021;47:101226.","journal-title":"Diabetes Metab"},{"key":"3089_CR59","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","volume":"368","author":"MK Ali","year":"2013","unstructured":"Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999\u20132010. N Engl J Med. 2013;368:1613\u201324.","journal-title":"N Engl J Med"},{"key":"3089_CR60","doi-asserted-by":"crossref","unstructured":"Velidakis N, Stachteas P, Gkougkoudi E, Papadopoulos C, Kadoglou NPE: Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review. Pharmaceuticals (Basel). 2024;17:568.","DOI":"10.3390\/ph17050568"},{"key":"3089_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","volume":"371","author":"PM Kearney","year":"2008","unstructured":"Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371:117\u201325.","journal-title":"Lancet"},{"key":"3089_CR62","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.2337\/dc24-S010","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","unstructured":"American Diabetes Association Professional Practice Committee. Cardiovascular disease and risk management: standards of care in Diabetes\u20142024. Diabetes Care. 2023;47:S179\u2013218.","journal-title":"Diabetes Care"},{"key":"3089_CR63","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2337\/dc11-0178","volume":"34","author":"J Wang","year":"2011","unstructured":"Wang J, Geiss LS, Cheng YJ, Imperatore G, Saydah SH, James C, et al. Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988\u20132008. Diabetes Care. 2011;34:1579\u201381.","journal-title":"Diabetes Care"},{"key":"3089_CR64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(24)00537-3","volume":"404","author":"AI Adler","year":"2024","unstructured":"Adler AI, Coleman RL, Leal J, Whiteley WN, Clarke P, Holman RR. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91). Lancet. 2024;404:145\u201355.","journal-title":"Lancet"},{"key":"3089_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078242","volume":"385","author":"N Simms-Williams","year":"2024","unstructured":"Simms-Williams N, Treves N, Yin H, Lu S, Yu O, Pradhan R, et al. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ. 2024;385:e078242.","journal-title":"BMJ"},{"key":"3089_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01414-3","volume":"20","author":"E Longato","year":"2021","unstructured":"Longato E, Di Camillo B, Sparacino G, Tramontan L, Avogaro A, Fadini GP. Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study. Cardiovasc Diabetol. 2021;20:222.","journal-title":"Cardiovasc Diabetol"},{"key":"3089_CR67","doi-asserted-by":"crossref","unstructured":"Gonzalez Perez A, Vizcaya D, S\u00e1ez ME, Lind M, Garcia Rodriguez LA: Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK. BMJ Open Diab Res Care. 2023;11:e003072.","DOI":"10.1136\/bmjdrc-2022-003072"},{"key":"3089_CR68","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ehf2.14213","volume":"10","author":"G Wolff","year":"2023","unstructured":"Wolff G, Lin Y, Akbulut C, Brockmeyer M, Parco C, Hoss A, et al. Meta-analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes. ESC Heart Fail. 2023;10:552\u201367.","journal-title":"ESC Heart Fail"},{"key":"3089_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00592-020-01576-8","volume":"58","author":"JCG Bak","year":"2021","unstructured":"Bak JCG, Sern\u00e9 EH, Kramer MHH, Nieuwdorp M, Verheugt CL. National diabetes registries: do they make a difference? Acta Diabetol. 2021;58:267\u201378.","journal-title":"Acta Diabetol"},{"key":"3089_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70112","volume":"42","author":"JJC Thomas","year":"2025","unstructured":"Thomas JJC, Lanzinger S, Soerensen KK, Imberg H, Schmid S, Barron E, et al. A cohort description and comparison of four European national diabetes registries for the REDDIE project. Diabet Med. 2025;42:e70112.","journal-title":"Diabet Med"},{"key":"3089_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02179-1","volume":"23","author":"H Claessen","year":"2024","unstructured":"Claessen H, Narres M, Heier M, Kvitkina T, Linkohr B, Wolff G, et al. Sex-specific trends in incidence of first myocardial infarction among people with and without diabetes between 1985 and 2016 in a German region. Cardiovasc Diabetol. 2024;23:110.","journal-title":"Cardiovasc Diabetol"},{"key":"3089_CR72","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","volume":"391","author":"EW Gregg","year":"2018","unstructured":"Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL, et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018;391:2430\u201340.","journal-title":"Lancet"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03089-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03089-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03089-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:06:21Z","timestamp":1774285581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03089-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3089"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03089-x","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}